Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia

IJMS, Free Full-Text

Frontiers Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia

Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia

Frontiers Molecular Approaches to Treating Pediatric Leukemias

Frontiers Pharmacologic Targeting of Chromatin Modulators As Therapeutics of Acute Myeloid Leukemia

Cancers, Free Full-Text

PDF) Menin–MLL1 Interaction Small Molecule Inhibitors: A Potential Therapeutic Strategy for Leukemia and Cancers

Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia

Challenges and opportunities in targeting the menin-MLL interaction.

Structure-Based Discovery of M-89 as a Highly Potent Inhibitor of the Menin-Mixed Lineage Leukemia (Menin-MLL) Protein–Protein Interaction

Designed to Kill: Novel Menin-MLL Inhibitors Target MLL-Rearranged Leukemia - ScienceDirect

Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia

Menin‑MLL inhibitors induce ferroptosis and enhance the anti‑proliferative activity of auranofin in several types of cancer cells

Pharmacologic Inhibition of the Menin-MLL Interaction Blocks Progression of MLL Leukemia In Vivo - ScienceDirect